Ells. These data recommend that potent adjuvants, for instance cationic adjuvant
Ells. These data suggest that potent adjuvants, which include cationic adjuvant formulation 09, render low-dose vaccination a feasible and promising approach for creating high-avidity T cells via vaccination. The Journal…